The COVID-19 pandemic in 2020 quickly changed how clinical trials are conducted. Many companies suddenly needed to switch to decentralized trial models to protect their studies and the safety of participants. Now the main question being asked is where do clinical trials go from here and what can we expect in 2021? And what does the future hold for emerging technologies, virtual trials, and patient centricity in the age of COVID?
In this webinar segment, Debbie Profit of Otsuka, Jeff Kasher of Patients Can’t Wait, and Craig Lipset of Clinical Innovation Partners address the integrity and reliability of data that is gathered from decentralized clinical trials, as well as the safety of patients enrolled in those trials.